Chathuri Daluwatte | Head of AI Diagnostics, Alexion, AstraZeneca Rare Disease

Chathuri Daluwatte, PhD has led organization-wide, nationwide, and global AI initiatives in the regulated life sciences industry that resulted in a competitive advantage. Her unique thought leadership stems from her technology background, business acumen, and regulatory experience. Daluwatte has bachelor’s degrees spanning fields of electronics, telecom, and computer science, along with a master’s degree in statistics, and a Ph.D. in biomedical engineering and has worked at bioMérieux and then in the U.S. Food and Drug Administration (FDA), both at the Center for Devices and Radiological Health (CDRH), and the Center for Drug Evaluation and Research (CDER). Her professional experience also includes working at Sanofi, across the value chain and the enterprise Chief Digital Office, leading development, and deployment of AI products at scale globally, while maintaining compliance. She is the Head of AI Diagnostics for Alexion, AstraZeneca Rare Disease. The opinions within this article are her own.